ELOXEloxx Pharmaceuticals, Inc. · NASDAQ (recently uplisted from OTC Expert/Pink Market via firm-commitment offering; symbol ELOX)
Effective Supply — the real overhangest.

From what's tradeable today to what's realistically coming. Bigger = more selling pressure ahead.

22.5K
Reported Float
29.52M
Tradeable Now
(estimated float)
▲ data says 22.5K — understated 1309.7×
39.23M
Effective Supply
48.00M
Fully Diluted
Dilution risk5/10
CONFIDENCE: MEDIUM
ELEVATEDAssessed Jun 9, 2026Trigger: EFFECT registration filingHIGHIn-the-money pre-funded warrant overhangHIGHSerial reverse split history

Score is driven by warrant overhang and recent activity, not by toxic converts. There are NO active variable-rate / floating-discount convertibles currently outstanding — the Domicilium bridge debt was fully converted to equity in Aug 2025. The dominant pending supply is ~10M post-split shares of deeply in-the-money $0.11 pre-funded warrants (~34% of float), economically equivalent to shares-in-waiting, though tempered by 4.99% ownership blockers and concentrated insider/fund holders unlikely to dump immediately. Recent activity is intense (Aug 2025 $17M raise, Feb 2026 Coastlands deal, 1-for-11 reverse split, June 2026 Nasdaq uplisting offering). Historical pattern is severe — five reverse splits since 1999 (1:3, 1:100, 1:20, 1:40, 1:11) signal repeated dilution-and-reset cycles.

Share Structure

Float to Fully Diluted Breakdown

LIKELY STALE

Reported float from Insight Sentry (29,523.944587 thousand, dated 2026-06-09, post-split / post-uplisting). Adjusted based on SEC filing analysis.

Float Discrepancy: our SEC analysis shows 29.52M vs 23K reported — understated 1309.7×

Insight Sentry float (~29.5M) appears current (2026-06-09) and post-split. The main event a stale feed could miss is the early-June Nasdaq uplisting offering, but this feed already reflects it. The largest un-modeled supply is ~10M post-split shares of deeply in-the-money $0.11 pre-funded warrants held by Coastlands/Domicilium/Aug-2025 SPA investors — these convert 1:1 to common when exercised and...

Reported Float23K0.0%
Warrants9.71M20.2%
pre-funded4.92M shares at $0.11
pre-funded2.78M shares at $0.11
pre-funded2.01M shares at $0.11
common0 shares
Other330K0.7%
Options / RSUs330K shares
≈ Estimated Actual Float

Reported float + filing adjustments

29.52M

MEDIUM confidence

Pending Shares as % of Float34%

Registered and convertible shares that could enter the float relative to current float size.

Fully Diluted48.00M100%

Share estimates are approximate. Convertible share counts based on current price. Review SEC filings for exact terms.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue
Dilution profile
Reverse splits (5)
  • 1-for-3·Jan 22, 1999~28 yr ago
  • 1-for-100·Oct 21, 2013~13 yr ago
  • 1-for-20·Dec 20, 2017~9 yr ago
  • 1-for-40·Dec 2, 2022~4 yr ago
  • 1-for-11·Jun 1, 2026~2 mo ago
Active mechanisms
  • ▸In-the-money $0.11 pre-funded warrants (~10M post-split shares, 1:1 exercise, partial 4.99% blockers)
  • ▸At-the-Market Sales Agreement referenced as active (capacity not disclosed)
  • ▸Underwriter over-allotment option (30-day) on uplisting offering
  • ▸Possible Coastlands preferred (Feb 2026, terms undisclosed)

Market Data

Price

$11.94

Market Cap

$500.7K

Outstanding

41.9K

Float

22.5K

Avg Volume

67.9K

Exchange: NASDAQ|Source: Insight Sentry